ARE THE COSTS OF OUTPATIENT INTERMITTENT INOTROPIC THERAPY IN SEVERE HEART-FAILURE JUSTIFIED - A RANDOMIZED CONTROLLED CLINICAL-TRIAL OF DOBUTAMINE AND MILRINONE
Mr. Mehra et al., ARE THE COSTS OF OUTPATIENT INTERMITTENT INOTROPIC THERAPY IN SEVERE HEART-FAILURE JUSTIFIED - A RANDOMIZED CONTROLLED CLINICAL-TRIAL OF DOBUTAMINE AND MILRINONE, Circulation, 96(8), 1997, pp. 1015-1015